HomeFull speed ahead. Keep track of advancements in every frontier

TheTechno Optimist.

Recursion—Recursion OS and pipelineRecursion—Recursion OS and pipelineRecursion—

Recursion

AI drug discovery from cell images

USpublicest. 2013recursion.com (opens recursion.com)Checked 25 Sep

The brief

Analyst view
  • Najat Khan succeeded co-founder Chris Gibson as CEO on 1 Jan 2026.
  • Merged with Exscientia in Nov 2024, adding AI-driven chemistry to its cell-imaging platform.
  • Partners include Roche/Genentech and Sanofi; its own drug list was cut in 2025.
Programs

Recursion, one program

Updated 5 Aug 2026
Recursion OS and pipelineRobots run millions of experiments where genes or chemicals are changed, and cells are stained and photographed. AI groups things with similar effects, hinting at targets and drugs.ProtoNextShow trial results from AI-found drugsUpdated 5 Aug 2026View program →
Research · Proto · Pilot · Deploy · Scaling

Peers

AI drug discovery · 3

Company & funding

HQ
US
Founded
2013

People

Key people
Primer